Andreas Halvorsen's position in Day One Biopharmaceuticals is currently worth $41.4 Million. That's 0.16% of their equity portfolio (73rd largest holding). The investor owns 2.93% of the outstanding Day One Biopharmaceuticals stock. The first Day One Biopharmaceuticals trade was made in Q2 2021. Since then Andreas Halvorsen bought shares two more times and sold shares on three occasions. The stake costed the investor $40.6 Million, netting the investor a gain of 1.9% so far.